Cargando…
Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents
A 70-year-old man with malignant lymphoma was subjected to a fourth course of chemotherapy using gemcitabine and cisplatin. During the intravenous infusion of anticancer agents, pain and redness was observed at the site of insertion. The patient was subsequently treated with the strongest topical st...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874355/ https://www.ncbi.nlm.nih.gov/pubmed/29093414 http://dx.doi.org/10.2169/internalmedicine.9329-17 |
_version_ | 1783310150039240704 |
---|---|
author | Okuda, Hiroto Masatsugu, Asako Sijimaya, Takako Arai, Rie |
author_facet | Okuda, Hiroto Masatsugu, Asako Sijimaya, Takako Arai, Rie |
author_sort | Okuda, Hiroto |
collection | PubMed |
description | A 70-year-old man with malignant lymphoma was subjected to a fourth course of chemotherapy using gemcitabine and cisplatin. During the intravenous infusion of anticancer agents, pain and redness was observed at the site of insertion. The patient was subsequently treated with the strongest topical steroids and topical cooling agents. However, 2 weeks later, the affected area turned yellow, and the histopathological findings revealed skin necrosis of the entire dermis layer. It took two and a half months to cure the lesion. Close attention should be paid to the development of skin necrosis even when irritant anticancer agents such as gemcitabine and cisplatin are administered. |
format | Online Article Text |
id | pubmed-5874355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-58743552018-03-29 Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents Okuda, Hiroto Masatsugu, Asako Sijimaya, Takako Arai, Rie Intern Med Case Report A 70-year-old man with malignant lymphoma was subjected to a fourth course of chemotherapy using gemcitabine and cisplatin. During the intravenous infusion of anticancer agents, pain and redness was observed at the site of insertion. The patient was subsequently treated with the strongest topical steroids and topical cooling agents. However, 2 weeks later, the affected area turned yellow, and the histopathological findings revealed skin necrosis of the entire dermis layer. It took two and a half months to cure the lesion. Close attention should be paid to the development of skin necrosis even when irritant anticancer agents such as gemcitabine and cisplatin are administered. The Japanese Society of Internal Medicine 2017-11-01 2018-03-01 /pmc/articles/PMC5874355/ /pubmed/29093414 http://dx.doi.org/10.2169/internalmedicine.9329-17 Text en Copyright © 2018 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Okuda, Hiroto Masatsugu, Asako Sijimaya, Takako Arai, Rie Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents |
title | Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents |
title_full | Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents |
title_fullStr | Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents |
title_full_unstemmed | Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents |
title_short | Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents |
title_sort | skin necrosis due to the extravasation of irritant anticancer agents |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874355/ https://www.ncbi.nlm.nih.gov/pubmed/29093414 http://dx.doi.org/10.2169/internalmedicine.9329-17 |
work_keys_str_mv | AT okudahiroto skinnecrosisduetotheextravasationofirritantanticanceragents AT masatsuguasako skinnecrosisduetotheextravasationofirritantanticanceragents AT sijimayatakako skinnecrosisduetotheextravasationofirritantanticanceragents AT arairie skinnecrosisduetotheextravasationofirritantanticanceragents |